基于miRNA测序分析清肺排毒汤防治小鼠急性肺损伤的分子机制研究
李龙雪1(), 万崇凡2, 张琦2, 雷茹婷2, 王潇玥3, 程乐妍2, 赖琦2, 刘荣华4()(), 刘漩1()(), 徐铁龙5()()
Molecular Mechanisms of Qingfei Paidu Decoction in the Prevention and Treatment of Acute Lung Injury in Mice Based on miRNA Sequencing
LI Longxue1(), WAN Chongfan2, ZHANG Qi2, LEI Ruting2, WANG Xiaoyue3, CHENG Leyan2, LAI Qi2, LIU Ronghua4()(), LIU Xuan1()(), XU Tielong5()()

图 5. 实时荧光定量PCR验证mmu-miR-203-3p差异表达
注:对照组,连续8 d灌胃给予超纯水;模型组,灌胃给予超纯水1 d,然后于第2~8天给予脂多糖(LPS)水溶液雾化建立急性肺损伤模型;QFPDD组,连续8 d灌胃给予清肺排毒汤(QFPDD),并于第2~8天给予LPS水溶液雾化建模。每组随机选取4只小鼠的肺组织进行实时荧光定量PCR分析。与对照组相比,**P<0.01;与模型组相比,##P<0.01。

Figure 5. Validation of differential expression of mmu-miR-203-3p by quantitative real-time PCR
Note: Control group, intragastrically administered ultrapure water for 8 consecutive days. Model group, intragastrically administered ultrapure water on day 1, followed by exposure to aerosolized lipopolysaccharide (LPS) solution on days 2–8 to establish the acute lung injury (ALI) model. QFPDD group, intragastrically administered Qingfei Paidu decoction (QFPDD) for 8 consecutive days, with concurrent exposure to aerosolized LPS solution on days 2–8 for ALI induction. Lung tissues from 4 randomly selected mice per group were used for quantitative real-time PCR analysis (n=4). Compared with the control group, **P < 0.01; compared with the model group, ##P < 0.01.